Mirzai R, Chang C, Greenspan A, Gershwin M E
Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, 95616-8660, USA.
J Asthma. 1999;36(1):77-95. doi: 10.3109/02770909909065152.
One of the challenging issues faced by allergists is a risk-benefit analysis on the use of corticosteroids. An uncommon, but serious complication of corticosteroids is the development of avascular necrosis (osteonecrosis). In this review we present the differential diagnosis and pathophysiology of osteonecrosis, with particular emphasis on steroids. Osteonecrosis of the femoral head is a common disorder that may be either naturally occurring or iatrogenic. With the exception of those cases labeled as idiopathic, the majority are the result of some insult to the vascular integrity of the affected hip. The reason for this disruption is manifold and can range from direct trauma to the more subtle or indirect compromise associated with fatty emboli or often an intravascular event such as that seen in sickle cell anemia. Although they are not totally understood, corticosteroids present a special problem because of susceptibility factors that may make some patients more likely to get osteonecrosis than others. The problem may be more complex, in that the association between corticosteroid use and osteonecrosis may be disease-dependent. In any case, any patient receiving long-term corticosteroids should be warned of this potentially debilitating complication.
过敏症专科医生面临的一个具有挑战性的问题是关于使用皮质类固醇的风险效益分析。皮质类固醇一种罕见但严重的并发症是缺血性坏死(骨坏死)的发生。在本综述中,我们介绍骨坏死的鉴别诊断和病理生理学,特别强调类固醇。股骨头坏死是一种常见疾病,可能是自然发生的,也可能是医源性的。除了那些被标记为特发性的病例外,大多数是由于对受影响髋关节血管完整性的某种损害所致。这种破坏的原因是多方面的,范围从直接创伤到与脂肪栓塞相关的更细微或间接的损害,或通常是血管内事件,如镰状细胞贫血中所见。尽管尚未完全了解,但由于易感性因素,皮质类固醇存在一个特殊问题,这些因素可能使一些患者比其他患者更容易发生骨坏死。问题可能更复杂,因为皮质类固醇使用与骨坏死之间的关联可能取决于疾病。无论如何,任何接受长期皮质类固醇治疗的患者都应被告知这种可能使人衰弱的并发症。